“Patients with malignant gastric outlet obstruction who have a good performance status are traditionally managed surgically to re-establish intake of solid food,” explained Dr Yorick van de Pavert (University Medical Centre Utrecht, the Netherlands) [1]. “Although this is an effective procedure, it has been associated with morbidities such as persistent gastroparesis.”
The ENDURO trial aimed to investigate whether an endoscopic approach could reduce the time to oral intake while maintaining comparable re-intervention rates [2]. The research team randomised 98 participants with gastric outlet syndrome caused by a metastatic or unresectable malignancy (1:1) to undergo either endoscopic ultrasonography-guided gastroenterostomy or surgical gastrojejunostomy. The primary endpoints were time to oral intake of solid food and re-intervention rate at 6 months.
Participants in the endoscopy arm had a median of 1 day to initiation of oral intake, compared to 3 days for participants in the surgery arm, representing a significant difference in favour of the endoscopy arm (HR 2.21; 95% CI 1.43–3.42; P=0.0003). Furthermore, the re-intervention rate for recurrent or persistent obstructive symptoms was 10% in the endoscopy arm and 12% in the surgery arm, clearly meeting the non-inferiority criterion. “In the endoscopy arm, 2 participants required surgical gastrojejunostomy and 3 participants received a second lumen-apposing metal stent,” Dr van de Pavert elaborated. “The 6 re-interventions in the surgery arm were all performed to install a feeding tube and/or provide parenteral nutrition.”
Finally, the median length of hospital stay was 1 day in the endoscopy arm and 4 days in the surgery arm (relative change 0.46; 95% CI 0.20–0.78; see Figure).
Figure: Secondary endpoint results from the ENDURO study [1]

In conclusion, endoscopic gastroenterostomy provided a faster time to resume oral intake and a shorter hospital stay while maintaining non-inferior re-intervention rates compared with a surgical approach.
- Van de Pavert YL, et al. Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO). OP001, Plenary Session, UEG Week, 4–7 October 2025, Berlin, Germany.
- Kastelijn JB, et al. Trials. 2023;24(1):608.
Copyright ©2025 Medicom Medical Publishers
Posted on
Previous Article
« Reducing TME burden with a risk-stratified approach in early rectal cancer Next Article
Early detection of pancreatic cancer with an AI tool may save lives »
« Reducing TME burden with a risk-stratified approach in early rectal cancer Next Article
Early detection of pancreatic cancer with an AI tool may save lives »
Table of Contents: UEGW 2025
Featured articles
Mufemilast advances to phase 3 following positive phase 2 results in UC
Diverse Top Research From UEG Week
Rabeprazole may be the preferred high-dose PPI in severe eGERD
Promising signs from a novel Helicobacter Pylori vaccine
Improving prevention and sustainability go hand-in-hand in IBD care
TRIASSIC: ESD superior to TAMIS for resection of non-pedunculated rectal lesions
Promising novel treatment option for functional dyspepsia
Latest Advancements in IBD
Intake of specific fibre subtypes linked to reduced risk of CD onset
Prospective insight into dietary patterns and relapse risk in IBD
Mufemilast advances to phase 3 following positive phase 2 results in UC
High-dose obefazimod is efficacious in UC regardless of prior therapy exposure
Can SIK3 inhibition become the Holy Grail for autoimmune diseases?
Relapse rate and risk factors after anti-TNF withdrawal in UC
TURN2: Well-prepared FMT shows efficacy in UC
Different outcomes of AI-read versus human-read endoscopies in the TITRATE study
Treatment efficacy of 7 therapies in perianal fistulising CD
ASTRO: Subcutaneous guselkumab maintains efficacy in UC through 2 years of follow-up
ANTHEM-UC: Oral IL-23 inhibitor delivers encouraging phase 2 data
Malignancies and Related Topics
Early detection of pancreatic cancer with an AI tool may save lives
Endoscopic approach preferred over surgery in gastric outlet syndrome
Reducing TME burden with a risk-stratified approach in early rectal cancer
PuraStat is effective and safe in real-world radiation proctopathy
Extended surveillance intervals after colorectal ESD may be safe and feasible
A machine learning model to improve bowel preparation quality monitoring
Can vedolizumab simplify the management of checkpoint inhibitor-induced enterocolitis?
Risk-stratified screening for CRC is more effective at the same spending rate
Highlights in Hepatology
Sugar-sweetened and non-sugar–sweetened beverages linked to MASLD risk
GLISTEN: Linerixibat meets primary endpoint in PBC-associated cholestatic pruritus
Even limited alcohol consumption is linked to increased MASLD risk
GLP-1 agonists in MASH: State-of-affairs
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com
